These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 11387867)

  • 21. Disabling obsessive thoughts responsive to antidepressants.
    Jenike MA; Armentano ME; Baer L
    J Clin Psychopharmacol; 1987 Feb; 7(1):33-5. PubMed ID: 3818991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacologic treatment of refractory pediatric obsessive compulsive disorder.
    Ferren T; Palmes GK; Kaplan SG
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):509-12. PubMed ID: 24024535
    [No Abstract]   [Full Text] [Related]  

  • 23. The adequacy of pharmacotherapy in outpatients with obsessive-compulsive disorder.
    Denys D; Van Megen H; Westenberg H
    Int Clin Psychopharmacol; 2002 May; 17(3):109-14. PubMed ID: 11981351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Complex treatment of obsessive states of different etiology].
    Kutin VP; Kutin GV
    Vrach Delo; 1978 Mar; (3):120-4. PubMed ID: 645020
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review.
    Bosman RC; Waumans RC; Jacobs GE; Oude Voshaar RC; Muntingh ADT; Batelaan NM; van Balkom AJLM
    Psychother Psychosom; 2018; 87(5):268-275. PubMed ID: 30041180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obsessive-compulsive disorder: historic review and update on the use of novel antidepressants.
    Winstead DK; Hurst CO; Salins C; Goodman A; Tynes LL
    Psychiatr Med; 1990; 8(4):49-58. PubMed ID: 2087570
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization.
    Koran LM; Leventhal JL; Fireman B; Jacobson A
    Am J Health Syst Pharm; 2000 Nov; 57(21):1972-8. PubMed ID: 11094651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Compliance, subdosage and overdosage of antidepressive agents in the first prescription in a hospital milieu].
    Vandel S; Bertschy G; Vandel B; Allers G; Volmat R
    Therapie; 1990; 45(2):145-9. PubMed ID: 2353327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence of anonymous medication before admission to the hospital (author's transl)].
    Linde OK
    Pharmakopsychiatr Neuropsychopharmakol; 1979 May; 12(3):286-90. PubMed ID: 39303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug statistics in 1993: benzodiazepines are more and more drugs for the elderly].
    Lennholm B
    Lakartidningen; 1994 Apr; 91(17):1675-7. PubMed ID: 8189893
    [No Abstract]   [Full Text] [Related]  

  • 31. Concerns about study on Beers criteria.
    Kelly WN
    Am J Health Syst Pharm; 2007 Jan; 64(2):138; author reply 138. PubMed ID: 17215461
    [No Abstract]   [Full Text] [Related]  

  • 32. Potentially inappropriate medications in hospitalized senior patients.
    Bonk ME; Krown H; Matuszewski K; Oinonen M
    Am J Health Syst Pharm; 2006 Jun; 63(12):1161-5. PubMed ID: 16754742
    [No Abstract]   [Full Text] [Related]  

  • 33. [Status of patients on antidepressants or tranquilizing agents for extended periods--results of a survey conducted by Kitasato University Hospital].
    Izawa S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Oct; 19(4):223-6. PubMed ID: 10637833
    [No Abstract]   [Full Text] [Related]  

  • 34. [The number of individuals with prescribed antidepressive agents has doubled].
    Ekedahl A
    Lakartidningen; 1996 Dec; 93(49):4528. PubMed ID: 8999235
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of the reliability and validity of a measure of anxiolytic drug-use intensity for pharmacoepidemiologic studies.
    Ried LD; Johnson RE
    Ann Pharmacother; 1992 Nov; 26(11):1441-6. PubMed ID: 1362096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzodiazepines on trial.
    Price DE; Singleton SJ; Feely MP
    Br Med J (Clin Res Ed); 1984 May; 288(6429):1534. PubMed ID: 6144349
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug exposure in register-based research-An expert-opinion based evaluation of methods.
    Tanskanen A; Taipale H; Koponen M; Tolppanen AM; Hartikainen S; Ahonen R; Tiihonen J
    PLoS One; 2017; 12(9):e0184070. PubMed ID: 28886089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inadequate pharmacotherapy in patients with obsessive-compulsive disorder].
    Denys D; van Megen HJ; Westenberg HG
    Ned Tijdschr Geneeskd; 2001 May; 145(19):914-8. PubMed ID: 11387867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I; Baruch Y; Barak Y
    Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.